Prolonged Hemocoagulase Agkistrodon Halys Pallas Administration Induces Hypofibrinogenemia in Patients with Hematological Disorders: A Clinical Analysis of 11 Patients
- 14 August 2017
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 34 (2) , 322-327
Abstract
Hemocoagulase Agkistrodon Halys Pallas, a well-established hemostatic agent used in China, has widespread applications in various conditions of bleeding and hemorrhages. Although it presents a low risk of vascular thrombosis, the agent can be easily tolerated and does not show any harmful effects, except allergy. However, long-term use of hemocoagulase may induce hypofibrinogenemia in some patients. Herein, we report 11 patients of prolonged administration of hemocoagulase Agkistrodon, with particular attention to the dynamic changes in their coagulation functions. A marked decline in the level of fibrinogen was observed in patients suffering from hematological disorders, following an extended exposure to hemocoagulase. Nevertheless, the low fibrinogen levels increased after withdrawal of the agent. Since the D-dimer level did not show any significant increase, hemocoagulase inducing lower fibrinogen may be considered to be a process of primary fibrinolysis. In conclusion, we suggested that hemocoagulase must be cautiously used in patients with hematological disorders, because of the potential risk of fibrinolysis; and the coagulation functions should be carefully evaluated during the administration of hemocoagulase.Keywords
This publication has 10 references indexed in Scilit:
- Hemocoagulase agkistrodon-induced anaphylactic shock: A case report and literature reviewInt. Journal of Clinical Pharmacology and Therapeutics, 2016
- [Hypofibrinogenemia caused by long-term administration of hemocoagulase: three cases report and literature review].Chinese Journal of Hematology, 2014
- A Double Blind Study on the Efficacy of Local Application of Hemocoagulase Solution in Wound HealingThe Journal of Contemporary Dental Practice, 2013
- Hemocoagulase Injection blood anesthesia in joint operationJournal of Medical Colleges of PLA, 2011
- A multicenter, phase III trial of hemocoagulase Agkistrodon: hemostasis, coagulation, and safety in patients undergoing abdominal surgeryChinese Medical Journal, 2010
- Are batroxobin agents effective for perioperative hemorrhage in thoracic surgery? A systematic review of randomized controlled trialsBlood Coagulation & Fibrinolysis, 2009
- Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary preventionBlood Coagulation & Fibrinolysis, 2007
- New Treatment of Neonatal Pulmonary Hemorrhage with Hemocoagulase in Addition to Mechanical VentilationNeonatology, 2005
- Snake venom thrombin-like enzymes: from reptilase to nowCellular and Molecular Life Sciences, 2004
- World Medical Association Declaration of HelsinkiJAMA, 2000